
CPTH2
CAS No. 357649-93-5
CPTH2( CPTH2 | CPTH 2 | CPTH-2 )
Catalog No. M14229 CAS No. 357649-93-5
CPTH2 is a specific histone acetyltransferase inhibitor modulating Gcn5 network in vitro and in vivo.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 40 | In Stock |
![]() ![]() |
5MG | 65 | In Stock |
![]() ![]() |
10MG | 102 | In Stock |
![]() ![]() |
25MG | 173 | In Stock |
![]() ![]() |
50MG | 260 | In Stock |
![]() ![]() |
100MG | 410 | In Stock |
![]() ![]() |
200MG | Get Quote | In Stock |
![]() ![]() |
500MG | Get Quote | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameCPTH2
-
NoteResearch use only, not for human use.
-
Brief DescriptionCPTH2 is a specific histone acetyltransferase inhibitor modulating Gcn5 network in vitro and in vivo.
-
DescriptionCPTH2 is a specific histone acetyltransferase inhibitor modulating Gcn5 network in vitro and in vivo, inhibits H3 acetylation and induces cell-cycle perturbation and apoptosis in U-937 cells; increases E1A CR3 transactivation of human adenovirus through inhibition of HAT GCN5, also reduces virus yield during infection; induces apoptosis and decreases the invasiveness of a ccRCC cell line through the inhibition of KAT3B.
-
In VitroCPTH2 (100 μM; 12, 24, 48 hours) causes a decrease in cell proliferation after as early as 12 h with a further significant reduction after 48 h stimulation. CPTH2 (100 μM; 12 or 48 hours) causes a comparable drop of the activity in both cell lines. CPTH2 (100 μM; 48 hours) produces a drastic increase in apoptotic/dead cell population after 48 h. CPTH2 (100 μM; 12, 24, 48 hours) shows a reduced acetylation of both global AcH3 histone and H3AcK18. CPTH2 (100 μM; 24, 48 hours) is capable to counteract invasion and migration of ccRCC-786-O cells in culture. CPTH2 (0.2, 0.5, 1 mM) inhibits the growth of a GCN5 deleted strain and a single catalytic mutant E173H. CPTH2 (0.6, 0.8 mM; for 24 hours) inhibits histone H3 acetylation in yeast cell cultures. CPTH2 inhibits the Gcn5p dependent functional network. Cell Proliferation Assay Cell Line:Papillary thyroid (K1) and clear cell Renal Cell Carcinoma (ccRCC-786-O) cell lines Concentration:100 μM Incubation Time:12, 24, 48 hoursResult:Caused a decrease in cell proliferation after as early as 12 h with a further significant reduction after 48 h stimulation. Cell Viability Assay Cell Line:K1 and ccRCC-786-O cell lines Concentration:100 μM Incubation Time:24 hours (K1 cell) and 48 hours (ccRCC-786-O cell)Result:Caused a comparable drop of the activity in both cell lines.Apoptosis Analysis Cell Line:ccRCC-786-O cells Concentration:100 μM Incubation Time:48 hours Result:Produced a drastic increase in apoptotic/dead cell population after 48 h.Western Blot Analysis Cell Line:ccRCC-786-O cells Concentration:100 μM Incubation Time:12, 24, 48 hours Result:Showed a reduced acetylation of both global AcH3 histone and H3AcK18.
-
In Vivo——
-
SynonymsCPTH2 | CPTH 2 | CPTH-2
-
PathwayChromatin/Epigenetic
-
TargetHAT
-
RecptorHAT
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number357649-93-5
-
Formula Weight291.797
-
Molecular FormulaC14H14ClN3S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 16.67 mg/mL (57.13 mM)
-
SMILESClC1=CC=C(C2=CSC(N/N=C3CCCC/3)=N2)C=C1
-
Chemical NameN-[4-(4-Chloro-phenyl)-thiazol-2-yl]-N'-cyclopentylidene-hydrazine
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Chimenti F, et al. J Med Chem. 2009 Jan 22;52(2):530-6.
2. Trisciuoglio D, et al. Clin Cancer Res. 2012 Jan 15;18(2):475-86.
3. Cocco E, et al. Clin Epigenetics. 2018 Apr 4;10:44.
4. Ablack JN, et al. J Virol. 2012 Aug;86(15):8198-209.
molnova catalog



related products
-
SPV 106
SPV 106 is the first mixed activator/inhibitor of Histone acetyltransferases (HATs).
-
CPTH6
CPTH6 is a thiazole derivative that can reduce histone acetylation and histone acetyltransferase (HAT) activity in human leukemia cells, CPTH6 is a specific Gcn5/pCAF inhibitor.
-
CPTH2
CPTH2 is a specific histone acetyltransferase inhibitor modulating Gcn5 network in vitro and in vivo.